Right Decisions
Maternity & Gynaecology Guidelines
Maternity
Back
Antenatal, general
Flowchart for Rh(D) Negative antenatal patients following a potentially sensitising event (if not already sensitised)

Please update your RDS mobile app to version 4.7.1

We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. When you install the update, you will see that each toolkit has a small QR code icon the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.

You may need to actively install the update to install RDS app version 4.7.1 to see this improvement. Installing this update is also strongly recommended to get the full benefits of the new contingency arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits.

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. To install latest updates:

On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Please get in touch with ann.wales3@nhs.scot with any questions.

Flowchart for Rh(D) Negative antenatal patients following a potentially sensitising event (if not already sensitised)

Maternity & Gynaecology Guidelines

Please report any inaccuracies or issues with this guideline using our online form

Standard Anti-D dose is 500 IU

Where anti-D is to be administered, this should be as soon as possible but always within 72 hours of the potentially sensitising event. If it is not given within 72 hours, every effort should still be made to administer the anti-D, as a dose given within 10 days may provide some protection. If there is uncertainty about dates it may be safer to administer anti-D. A group and retain sample should be sent to the Lab prior to administration of Anti-D

Anti-D administered via this flowchart will not affect, or be affected by RAADP.
Flowchart to be used in conjunction with other guidelines i.e. Antepartum Haemorrhage.

Related guideline: Anti-D administration following potentially sensitising events in Rhesus Negative women

Resources

Use the button below to access this item.

Access this resource

Last reviewed: 01/12/2018

Next review date: 01/12/2023

Author(s): Dr Fiona Mackenzie, Consultant Obstetrician PRM on behalf of GONEC.

Approved By: GONEC